Read this whitepaper for a comprehensive overview of the “what” and the “how” for approaching industry-specific legislation in 2026.

We cover financial services, energy, manufacturing and healthcare industries, across the UK, EU and US, and share our framework for approaching international legislation whilst maintaining competitive innovation.
Financial services firms face penalties up to €35 million under the EU AI Act.
Healthcare organisations navigate dual regulatory frameworks for AI medical devices.
Energy companies managing critical infrastructure through AI face heightened scrutiny across three jurisdictions.
And manufacturing sits at the intersection of innovation incentives and emerging compliance requirements.

The challenge?

Regulatory frameworks vary wildly by industry and geography. How do multi-national companies adhere compliantly, without stifling internal innovation?

What's acceptable in UK financial services, triggers mandatory conformity assessments in the EU. Healthcare AI approved by the FDA faces completely different requirements under the EU's Medical Device Regulation. A manufacturing AI system classified as low-risk in the US, can become high-risk critical infrastructure in the EU energy sector.

Most enterprises are getting this wrong. A recent Bank of England and FCA survey revealed 75% of UK financial services firms already use AI, but fewer than half have comprehensive governance frameworks addressing cross-border requirements. Despite Europe's manufacturing expertise, only about 20% of German companies successfully use AI in daily operations as of 2024, according to a recent study. And the same is reflected across other industries, highly-regulated or not.

Why this matters now

The EU AI Act's first major enforcement deadlines arrived in February 2025, with high-risk system requirements taking effect August 2026. The UK announced it won't introduce AI-specific financial services legislation until late 2026, creating a temporary regulatory arbitrage opportunity. US states are enacting conflicting AI requirements whilst federal oversight remains minimal.

The window for strategic positioning is closing. Organisations that understand these regulatory landscapes today will establish competitive advantages through faster deployment, reduced risk and enhanced stakeholder trust.

The governance-innovation paradox is real: Overly cautious approaches stifle competitive advantage, whilst insufficient governance creates legal and reputational risk. This whitepaper shows you exactly where regulatory lines are drawn and shares a comprehensive framework so you can innovate confidently within them.

What you'll gain

Clarity on compliance requirements for your specific industry and markets
Strategic insight into regulatory timing and enforcement priorities
Practical frameworks for balancing governance with innovation velocity
Competitive intelligence on how regulatory divergence creates opportunities

Download the full AI Regulation Playbook

Perfect for: CTOs, Chief Strategy Officers, Chief Information Officers, and technology leaders in financial services, healthcare, energy and manufacturing enterprises operating in UK, European or US markets.